SII applies to Indian authorities for full market authorisation of Covishield
New Delhi Dec 31 PTI Serum Institute of India SII CEO Adar Poonawala on Friday said it has applied to Indian authorities for full market authorisation of Covishield stating supplies of the COVID-19 vaccine have exceeded 125 crore doses SII had partnered with the developer of Covishield AstraZeneca for the supply of the vaccine to the Indian government which had in January this year granted emergency use authorisation in the country Supplies of the COVISHIELD vaccine in India have exceeded 125 billion doses The government of India now has enough data for full market authorisation and therefore SerumInstIndia has applied to the CDSCOINDIAINF DCGI andMoHFWINDIA for this permission Poonawala said in a tweet tagging the Central Drugs Standard Control Organisation CDSCO and Ministry of Health and Family Welfare PTI RKL DRR
New Delhi Dec 31 PTI Serum Institute of India SII CEO Adar Poonawala on Friday said it has applied to Indian authorities for full market authorisation of Covishield stating supplies of the COVID-19 vaccine have exceeded 125 crore doses SII had partnered with the developer of Covishield AstraZeneca for the supply of the vaccine to the Indian government which had in January this year granted emergency use authorisation in the country Supplies of the COVISHIELD vaccine in India have exceeded 125 billion doses The government of India now has enough data for full market authorisation and therefore SerumInstIndia has applied to the CDSCOINDIAINF DCGI andMoHFWINDIA for this permission Poonawala said in a tweet tagging the Central Drugs Standard Control Organisation CDSCO and Ministry of Health and Family Welfare PTI RKL DRR
